Cardinal Health Inc (CAH)

Currency in USD
278.32
-0.94(-0.33%)
Closed·
278.18-0.14(-0.05%)
·
CAH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
275.92280.21
52 wk Range
180.45286.29
Key Statistics
Prev. Close
279.25
Open
277.53
Day's Range
275.92-280.21
52 wk Range
180.45-286.29
Volume
997.14K
Average Volume (3m)
1.69M
1-Year Change
34.4736%
Book Value / Share
-13.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CAH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
300.80
Upside
+8.08%
Members' Sentiments
Bearish
Bullish
ProTips
8 analysts have revised their earnings downwards for the upcoming period

Cardinal Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

14 Buy
3 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 300.80
(+8.08% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy320.00+14.98%275.00MaintainNov 18, 2026
Wells Fargo
Buy321.00+15.33%277.00MaintainNov 17, 2026
Argus
Buy309.00+11.02%264.00MaintainNov 12, 2026
JPMorgan
Hold286.00+2.76%260.00MaintainNov 10, 2026
TD Cowen
Buy304.00+9.23%280.00MaintainNov 09, 2026

Cardinal Health Inc SWOT Analysis


Financial Triumph
Cardinal Health surpasses Q1 expectations, raising FY25 EPS guidance amid strong pharmaceutical and specialty segment performance
Strategic Expansion
Acquisition of Integrated Oncology Network for $1.115B signals shift to offensive growth strategy in community oncology market
Segment Dynamics
Explore the contrasting performances of Cardinal Health's divisions, with pharmaceutical success offsetting challenges in medical products
Market Positioning
Analysts set price targets ranging from $107 to $133, reflecting confidence in Cardinal Health's growth potential and strategic direction
Read full SWOT analysis

Cardinal Health Inc Earnings Call Summary for Q4/2026

  • Cardinal Health Q4 adjusted EPS of $2.60 beat estimates of $2.41 by 7.88%; revenue of $63.7B missed forecast by 2.33%, shares surged 7.62%.
  • Fiscal 2026 revenue rose 14% to $254B with adjusted free cash flow reaching $5B; company authorized $5B increase in buyback program to $6.4B total.
  • Management guided fiscal 2027 adjusted EPS of $12.40-$12.60, implying 13%-15% growth, with free cash flow forecast of $3.5B-$4B and minimum $1B buyback.
  • Pharmaceutical segment expected to grow revenue 3%-5% and profit 8%-11%; other growth businesses projected to expand revenue 11%-13% in fiscal 2027.
  • CEO Hollar noted non-GAAP EPS more than doubled since 2022; executives cited strong execution but expect normalized growth after unusually high 2026 demand.
Last Updated: 2026-08-11, 09:48 a/m
Read Full Transcript

Earnings

Latest Release
Nov 05, 2026
EPS / Forecast
3.26 / 2.95
Revenue / Forecast
67.5B / 66.59B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.75
Dividend Yield
0.74%
Industry Median 2.10%
Annualized payout
2.06
Paid quarterly
5-Years Growth
+1.00%
Growth Streak

CAH Income Statement

Compare CAH to Peers and Sector

Metrics to compare
CAH
Peers
Sector
Relationship
P/E Ratio
35.5x21.5x−0.2x
PEG Ratio
2.15−0.220.00
Price/Book
−21.3x3.1x2.6x
Price / LTM Sales
0.3x1.6x2.7x
Upside (Analyst Target)
8.1%0.0%68.5%
Fair Value Upside
Unlock14.0%11.5%Unlock

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Employees
61344

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
111.24M48.13%31.58B
Other Institutional Investors
98.44M42.59%27.94B
Public Companies & Retail Investors
21.46M9.28%6.09B
Total
231.14M100.00%65.61B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.11.46%26,490,6337,519,366
Vanguard Capital Management, LLC7.19%16,621,1264,717,907

People Also Watch

282.29
ITW
+0.22%
82.91
LEN
+0.69%
77.92
SYY
-0.09%
373.86
MPC
-5.23%
51.33
CSX
+0.37%

FAQ

What Is the Cardinal Health (CAH) Stock Price Today?

The Cardinal Health stock price today is 278.32 USD.

What Stock Exchange Does Cardinal Health Trade On?

Cardinal Health is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Cardinal Health?

The stock symbol for Cardinal Health is "CAH."

Does Cardinal Health Pay Dividends? What’s The Current Dividend Yield?

The Cardinal Health dividend yield is 0.7%%.

What Is the Cardinal Health Market Cap?

As of today, Cardinal Health market cap is 64.54B USD.

What Is Cardinal Health's Earnings Per Share (TTM)?

The Cardinal Health EPS (TTM) is 7.75.

When Is the Next Cardinal Health Earnings Date?

Cardinal Health will release its next earnings report on Feb 04, 2027.

From a Technical Analysis Perspective, Is CAH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cardinal Health Stock Split?

Cardinal Health has split 11 times.

How Many Employees Does Cardinal Health Have?

Cardinal Health has 61344 employees.

What is the current trading status of Cardinal Health (CAH)?

As of Nov 19, 2026, Cardinal Health (CAH) is trading at a price of 278.32 USD, with a previous close of 279.25 USD. The stock has fluctuated within a day range of 275.92 USD to 280.21 USD, while its 52-week range spans from 180.45 USD to 286.29 USD.

What Is Cardinal Health (CAH) Price Target According to Analysts?

The average 12-month price target for Cardinal Health is 300.80 USD, with a high estimate of 330 USD and a low estimate of 260 USD. 14 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +8.08% Upside potential.

What Is the CAH Premarket Price?

CAH's last pre-market stock price is 278.00 USD. The pre-market share volume is 630.00, and the stock has decreased by -1.25, or -0.45%.

What Is the CAH After Hours Price?

CAH's last after hours stock price is 278.18 USD, the stock has decreased by -0.14, or -0.05%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.